Ident. | Authors (with country if any) | Title |
---|
000004 |
Susan H. Fox [Canada] ; Leonard Verhagen Metman [États-Unis] ; John G. Nutt [États-Unis] ; Matthew Brodsky [États-Unis] ; Stewart A. Factor [États-Unis] ; Anthony E. Lang [Canada] ; Laura E. Pope [États-Unis] ; Nadine Knowles [États-Unis] ; João Siffert [États-Unis] | Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease. |
000015 |
Sali M K. Farhan [Canada] ; Robert Bartha [Canada] ; Sandra E. Black [Canada] ; Dale Corbett [Canada] ; Elizabeth Finger [Canada] ; Morris Freedman [Canada] ; Barry Greenberg [Canada] ; David A. Grimes [Canada] ; Robert A. Hegele [Canada] ; Chris Hudson [Canada] ; Peter W. Kleinstiver [Canada] ; Anthony E. Lang [Canada] ; Mario Masellis [Canada] ; William E. Mcilroy [Canada] ; Paula M. Mclaughlin [Canada] ; Manuel Montero-Odasso [Canada] ; David G. Munoz [Canada] ; Douglas P. Munoz [Canada] ; Stephen Strother [Canada] ; Richard H. Swartz [Canada] ; Sean Symons [Canada] ; Maria Carmela Tartaglia [Canada] ; Lorne Zinman [Canada] ; Michael J. Strong [Canada] | The Ontario Neurodegenerative Disease Research Initiative (ONDRI). |
000043 |
Alberto J. Espay [États-Unis] ; Patrik Brundin [États-Unis] ; Anthony E. Lang [Canada] | Precision medicine for disease modification in Parkinson disease. |
000049 |
Werner Poewe [Autriche] ; Klaus Seppi [Autriche] ; Caroline M. Tanner [États-Unis] ; Glenda M. Halliday [Australie] ; Patrik Brundin [États-Unis] ; Jens Volkmann [Allemagne] ; Anette-Eleonore Schrag [Royaume-Uni] ; Anthony E. Lang [Canada] | Parkinson disease. |
000052 |
Elizabeth J. Slow [Canada] ; Anthony E. Lang [Canada] | Oculogyric crises: A review of phenomenology, etiology, pathogenesis, and treatment. |
000076 |
Usman Saeed [Canada] ; Jordana Compagnone [Canada] ; Richard I. Aviv [Canada] ; Antonio P. Strafella [Canada] ; Sandra E. Black [Canada] ; Anthony E. Lang [Canada] ; Mario Masellis [Canada] | Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts |
000077 |
Naomi P. Visanji [Canada] ; Grace S. Bhudhikanok [États-Unis] ; Tiago A. Mestre [Canada] ; Taneera Ghate [Canada] ; Kaviraj Udupa [Canada] ; Amaal Aldakheel [Canada] ; Barbara S. Connolly [Canada] ; Carmen Gasca-Salas [Canada] ; Drew S. Kern [Canada] ; Jennifer Jain [Canada] ; Elizabeth J. Slow [Canada] ; Achinoam Faust-Socher [Canada] ; Sam Kim [États-Unis] ; Ruksana Azhu Valappil [États-Unis] ; Farah Kausar [États-Unis] ; Ekaterina Rogaeva [Canada] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis] ; Birgitt Schüle [États-Unis] ; Anthony E. Lang [Canada] ; Samuel M. Goldman [États-Unis] ; Connie Marras [Canada] | Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease. |
000084 |
Sang Soo Cho [Canada] ; Kelly Aminian [Canada] ; Crystal Li [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes. |
000091 |
Alberto J. Espay [États-Unis] ; Anthony E. Lang [Canada] ; Roberto Erro [Italie] ; Aristide Merola [États-Unis] ; Alfonso Fasano [Canada] ; Alfredo Berardelli [Italie] ; Kailash P. Bhatia [Royaume-Uni] | Essential pitfalls in "essential" tremor. |
000107 |
Alberto J. Espay [États-Unis] ; Anthony E. Lang [Canada] | Common Myths in the Use of Levodopa in Parkinson Disease: When Clinical Trials Misinform Clinical Practice. |
000108 |
Günter U. Höglinger [Allemagne] ; Gesine Respondek [Allemagne] ; Maria Stamelou [Grèce] ; Carolin Kurz [Allemagne] ; Keith A. Josephs [États-Unis] ; Anthony E. Lang [Canada] ; Brit Mollenhauer [Allemagne] ; Ulrich Müller [Allemagne] ; Christer Nilsson [Suède] ; Jennifer L. Whitwell [États-Unis] ; Thomas Arzberger [Allemagne] ; Elisabet Englund [Suède] ; Ellen Gelpi [Espagne] ; Armin Giese [Allemagne] ; David J. Irwin [États-Unis] ; Wassilios G. Meissner [France] ; Alexander Pantelyat [États-Unis] ; Alex Rajput [Canada] ; John C. Van Swieten [Pays-Bas] ; Claire Troakes [Royaume-Uni] ; Angelo Antonini [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; Yvette Bordelon [États-Unis] ; Yaroslau Compta [Espagne] ; Jean-Christophe Corvol [France] ; Carlo Colosimo [Italie] ; Dennis W. Dickson [États-Unis] ; Richard Dodel [Allemagne] ; Leslie Ferguson [Canada] ; Murray Grossman [États-Unis] ; Jan Kassubek [Allemagne] ; Florian Krismer [Autriche] ; Johannes Levin [Allemagne] ; Stefan Lorenzl [Autriche] ; Huw R. Morris [Royaume-Uni] ; Peter Nestor [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Gil Rabinovici [États-Unis] ; James B. Rowe [Royaume-Uni] ; Gerard D. Schellenberg [États-Unis] ; Klaus Seppi [Autriche] ; Thilo Van Eimeren [Allemagne] ; Gregor K. Wenning [Autriche] ; Adam L. Boxer [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Irene Litvan [États-Unis] | Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. |
000127 |
Chi Wang Ip [Allemagne] ; Laura-Christin Klaus [Allemagne] ; Akua A. Karikari [Allemagne] ; Naomi P. Visanji ; Jonathan M. Brotchie ; Anthony E. Lang ; Jens Volkmann [Allemagne] ; James B. Koprich | AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease |
000138 |
Naomi P. Visanji [Canada] ; Jonathan M. Brotchie [Canada] ; Lorraine V. Kalia [Canada] ; James B. Koprich [Canada] ; Anurag Tandon [Canada] ; Joel C. Watts [Canada] ; Anthony E. Lang [Canada] | α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era. |
000229 |
P. Justin Rossi [États-Unis] ; Aysegul Gunduz [États-Unis] ; Jack Judy [États-Unis] ; Linda Wilson [États-Unis] ; Andre Machado [États-Unis] ; James J. Giordano [États-Unis] ; W. Jeff Elias [États-Unis] ; Marvin A. Rossi [États-Unis] ; Christopher L. Butson [États-Unis] ; Michael D. Fox [États-Unis] ; Cameron C. Mcintyre [États-Unis] ; Nader Pouratian [États-Unis] ; Nicole C. Swann [États-Unis] ; Coralie De Hemptinne [États-Unis] ; Robert E. Gross [États-Unis] ; Howard J. Chizeck [États-Unis] ; Michele Tagliati [États-Unis] ; Andres M. Lozano [Canada] ; Wayne Goodman [États-Unis] ; Jean-Philippe Langevin [États-Unis] ; Ron L. Alterman [États-Unis] ; Umer Akbar [États-Unis] ; Greg A. Gerhardt [États-Unis] ; Warren M. Grill [États-Unis] ; Mark Hallett [États-Unis] ; Todd Herrington [États-Unis] ; Jeffrey Herron [États-Unis] ; Craig Van Horne [États-Unis] ; Brian H. Kopell [États-Unis] ; Anthony E. Lang [Canada] ; Codrin Lungu [États-Unis] ; Daniel Martinez-Ramirez [États-Unis] ; Alon Y. Mogilner [États-Unis] ; Rene Molina [États-Unis] ; Enrico Opri [États-Unis] ; Kevin J. Otto [États-Unis] ; Karim G. Oweiss [États-Unis] ; Yagna Pathak [États-Unis] ; Aparna Shukla [États-Unis] ; Jonathan Shute [États-Unis] ; Sameer A. Sheth [États-Unis] ; Ludy C. Shih [États-Unis] ; G. Karl Steinke [États-Unis] ; Alexander I. Tröster [États-Unis] ; Nora Vanegas [États-Unis] ; Kareem A. Zaghloul [États-Unis] ; Leopoldo Cendejas-Zaragoza [États-Unis] ; Leonard Verhagen [États-Unis] ; Kelly D. Foote [États-Unis] ; Michael S. Okun [États-Unis] | Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies |
000241 |
Sarah Coakeley [Canada] ; Sang Soo Cho [Canada] ; Yuko Koshimori [Canada] ; Pablo Rusjan [Canada] ; Madeleine Harris [Canada] ; Christine Ghadery [Canada] ; Jinhee Kim [Canada] ; Anthony E. Lang [Canada] ; Alan Wilson [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Positron emission tomography imaging of tau pathology in progressive supranuclear palsy. |
000252 |
Benzi M. Kluger [États-Unis] ; Karen Herlofson [Norvège] ; Kelvin L. Chou [États-Unis] ; Jau-Shin Lou [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anthony E. Lang [Canada] ; Daniel Weintraub [États-Unis] ; Joseph Friedman [États-Unis] | Parkinson's disease-related fatigue: A case definition and recommendations for clinical research. |
000255 |
Lorraine V. Kalia [Canada] ; Anthony E. Lang [Canada] | Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD. |
000260 |
Andrew D. Robertson [Canada] ; Michelle A. Messner [Canada] ; Zahra Shirzadi [Canada] ; Galit Kleiner-Fisman [Canada] ; Joyce Lee [Canada] ; Julia Hopyan [Canada] ; Anthony E. Lang [Canada] ; Sandra E. Black [Canada] ; Bradley J. Macintosh [Canada] ; Mario Masellis [Canada] | Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. |
000276 |
Ming Zhang [Canada] ; Zhengrui Xi [Canada] ; Shilun Fang [Canada] ; Mahdi Ghani [Canada] ; Christine Sato [Canada] ; Danielle Moreno [Canada] ; Yan Liang [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease. |
000298 |
Tiago A. Mestre [Canada] ; Christos Sidiropoulos [Canada] ; Clement Hamani [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] | Long-term double-blinded unilateral pedunculopontine area stimulation in Parkinson's disease. |
000353 |
Joseph H. Friedman [États-Unis] ; James C. Beck [États-Unis] ; Kelvin L. Chou [États-Unis] ; Gracia Clark [États-Unis] ; Christopher P. Fagundes [États-Unis] ; Christopher G. Goetz [États-Unis] ; Karen Herlofson [Norvège] ; Benzi Kluger [États-Unis] ; Lauren B. Krupp [États-Unis] ; Anthony E. Lang [Canada] ; Jao-Shin Lou [États-Unis] ; Laura Marsh [États-Unis] ; Anne Newbould [États-Unis] ; Daniel Weintraub [États-Unis] | Fatigue in Parkinson's disease: report from a mutidisciplinary symposium |
000355 |
Tiago A. Mestre [Canada] ; Anthony E. Lang [Canada] ; Michael S. Okun [États-Unis] | Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects. |
000380 |
Mario Masellis [Canada] ; Shannon Collinson [Canada] ; Natalie Freeman [Canada] ; Maria Tampakeras [Canada] ; Joseph Levy [Israël] ; Amir Tchelet [Israël] ; Eli Eyal [Israël] ; Elijahu Berkovich [Israël] ; Rom E. Eliaz [Israël] ; Victor Abler [Israël] ; Iris Grossman [Israël] ; Cheryl Fitzer-Attas [Israël] ; Arun Tiwari [Canada] ; Michael R. Hayden [Israël] ; James L. Kennedy [Canada] ; Anthony E. Lang [Canada] ; Jo Knight [Royaume-Uni] | Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study. |
000386 |
Yuko Koshimori [Canada] ; Sang-Soo Cho [Canada] ; Marion Criaud [Canada] ; Leigh Christopher [Canada] ; Mark Jacobs [Canada] ; Christine Ghadery [Canada] ; Sarah Coakeley [Canada] ; Madeleine Harris [Canada] ; Romina Mizrahi [Canada] ; Clement Hamani [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Disrupted Nodal and Hub Organization Account for Brain Network Abnormalities in Parkinson’s Disease |
000394 |
Steven R. Livingstone [Canada, États-Unis] ; Esztella Vezer [Canada] ; Lucy M. Mcgarry [Canada] ; Anthony E. Lang [Canada] ; Frank A. Russo [Canada] | Deficits in the Mimicry of Facial Expressions in Parkinson's Disease |
000399 |
Kaviraja Udupa ; Nina Bahl ; Zhen Ni ; Carolyn Gunraj ; Filomena Mazzella ; Elena Moro [France] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang ; Robert Chen [Canada] | Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease. |
000400 |
Marion Criaud [Canada, France] ; Leigh Christopher [Canada] ; Philippe Boulinguez [France] ; Benedicte Ballanger [France] ; Anthony E. Lang [Canada] ; Sang S. Cho [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Contribution of Insula in Parkinson’s Disease: A Quantitative Meta-Analysis Study |
000415 |
Carmen Gasca-Salas [Canada, Espagne] ; Mario Masellis [Espagne, Canada] ; Edwin Khoo [Canada] ; Binit B. Shah [États-Unis] ; David Fisman [Canada] ; Anthony E. Lang [Canada] ; Galit Kleiner-Fisman [Canada] | Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis |
000441 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Peter C. Austin [Canada] ; Cindy Lau [Canada] ; David R. Urbach [Canada] | Appendectomy in mid and later life and risk of Parkinson's disease: A population-based study. |
000466 |
Sean J. Udow [Canada] ; Andrew D. Robertson [Canada] ; Bradley J. Macintosh [Canada] ; Alberto J. Espay [États-Unis] ; James B. Rowe [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mario Masellis [Canada] | 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? |
000477 |
Joaquin A. Vizcarra [Pérou] ; Anthony E. Lang [Canada] ; Kapil D. Sethi [États-Unis] ; Alberto J. Espay [États-Unis] | Vascular parkinsonism: Deconstructing a syndrome |
000506 |
Anthony E. Lang ; A Jon Stoessl | The Saskatchewan Movement Disorders Program: Commitment Pays Off. |
000548 |
Camila C. Aquino [Canada] ; Anthony E. Lang [Canada] | Restless genital syndrome--in reply. |
000549 |
Nancy J. Butcher ; Wai Lun Alan Fung ; Laura Fitzpatrick ; Alina Guna ; Danielle M. Andrade ; Anthony E. Lang ; Eva W. C. Chow ; Anne S. Bassett | Response to clozapine in a clinically identifiable subtype of schizophrenia |
000578 |
Wai Lun Alan Fung [Canada] ; Nancy J. Butcher [Canada] ; Gregory Costain [Canada] ; Danielle M. Andrade [Canada] ; Erik Boot [Canada, Pays-Bas] ; Eva W. C. Chow [Canada] ; Brian Chung [République populaire de Chine] ; Cheryl Cytrynbaum [Canada] ; Hanna Faghfoury [Canada] ; Leona Fishman [Canada] ; Sixto García-Mi Aúr [Espagne] ; Susan George [Canada] ; Anthony E. Lang [Canada] ; Gabriela Repetto [Chili] ; Andrea Shugar [Canada] ; Candice Silversides [Canada] ; Ann Swillen [Belgique] ; Therese Van Amelsvoort [Pays-Bas] ; Donna M. Mcdonald-Mcginn [États-Unis] ; Anne S. Bassett [Canada] | Practical guidelines for managing adults with 22q11.2 deletion syndrome |
000581 |
Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. Szaflarski | Placebo effect of medication cost in Parkinson disease |
000599 |
Lorraine V. Kalia [Canada] ; Anthony E. Lang [Canada] | Parkinson's disease. |
000638 |
Erik Boot [Canada, Pays-Bas] ; Nancy J. Butcher [Canada] ; Thérèse Amj Van Amelsvoort [Pays-Bas] ; Anthony E. Lang [Canada] ; Connie Marras [Canada] ; Margarita Pondal [Canada] ; Danielle M. Andrade [Canada] ; Wai Lun Alan Fung [Canada] ; Anne S. Bassett [Canada] | Movement Disorders and Other Motor Abnormalities in Adults With 22q11.2 Deletion Syndrome |
000674 |
Anthony E. Lang ; Ramon L. Rodriguez ; James T. Boyd ; Sylvain Chouinard ; Cindy Zadikoff ; Alberto J. Espay ; John T. Slevin ; Hubert H. Fernandez ; Mark F. Lew ; David A. Stein ; Per Odin ; Victor S. C. Fung ; Fabian Klostermann ; Alfonso Fasano ; Peter V. Draganov ; Nathan Schmulewitz ; Weining Z. Robieson ; Susan Eaton ; Krai Chatamra ; Janet A. Benesh ; Jordan Dubow | Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials |
000682 |
Anthony E. Lang [Canada] | In pursuit of prodromal Parkinson's disease. |
000692 |
Yuko Koshimori [Canada] ; Ji-Hyun Ko [Canada] ; Romina Mizrahi [Canada] ; Pablo Rusjan [Canada] ; Rostom Mabrouk [Canada] ; Mark F. Jacobs [Canada] ; Leigh Christopher [Canada] ; Clement Hamani [Canada] ; Anthony E. Lang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease |
000701 |
Ai Huey Tan [Malaisie] ; Sanjiv Mahadeva [Malaisie] ; Connie Marras [Canada] ; Abdul Malik Thalha [Malaisie] ; Chiun Khang Kiew [Malaisie] ; Chia Ming Yeat [Malaisie] ; Sheang Wen Ng [Malaisie] ; Sheau Phing Ang [Malaisie] ; Siew Kian Chow [Malaisie] ; Mun Fai Loke [Malaisie] ; Jamunarani S. Vadivelu [Malaisie] ; Norlinah Ibrahim [Malaisie] ; Hoi Sen Yong [Malaisie] ; Chong Tin Tan [Malaisie] ; Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Shen-Yang Lim [Malaisie] | Helicobacter pylori infection is associated with worse severity of Parkinson's disease. |
000744 |
Sang Jin Kim ; Kaviraja Udupa ; Zhen Ni ; Elena Moro ; Carolyn Gunraj ; Filomena Mazzella ; Andres M. Lozano ; Mojgan Hodaie ; Anthony E. Lang ; Robert Chen | Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease |
000752 |
Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie] | Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion. |
000764 |
Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Anthony E. Lang [Canada] | Disease-modifying strategies for Parkinson's disease. |
000775 |
Camila C. Aquino [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Deep brain stimulation for Parkinson disease in elderly individuals. |
000792 |
Naomi P. Visanji ; Connie Marras ; Drew S. Kern ; Amaal Al Dakheel ; Andrew Gao ; Louis W. C. Liu ; Anthony E. Lang ; Lili-Naz Hazrati | Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease |
000795 |
Lorraine V. Kalia ; Anthony E. Lang ; Lili-Naz Hazrati ; Shinsuke Fujioka ; Zbigniew K. Wszolek ; Dennis W. Dickson ; Owen A. Ross ; Vivianna M. Van Deerlin ; John Q. Trojanowski ; Howard I. Hurtig ; Roy N. Alcalay ; Karen S. Marder ; Lorraine N. Clark ; Carles Gaig ; Eduardo Tolosa ; Javier Ruiz-Martínez ; Jose F. Marti-Masso ; Isidre Ferrer ; Adolfo L Pez De Munain ; Samuel M. Goldman ; Birgitt Schüle ; J. William Langston ; Jan O. Aasly ; Maria T. Giordana ; Vincenzo Bonifati ; Andreas Puschmann ; Margherita Canesi ; Gianni Pezzoli ; Andre Maues De Paula ; Kazuko Hasegawa ; Charles Duyckaerts ; Alexis Brice ; A. Jon Stoessl ; Connie Marras | Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease |
000812 |
Isabelle Beaulieu-Boire [Canada] ; Anthony E. Lang | Behavioral effects of levodopa. |
000922 |
Tiago A. Mestre [Canada] ; Alberto J. Espay ; Connie Marras ; Mark H. Eckman ; Pierre Pollak ; Anthony E. Lang | Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better. |
000936 |
Leigh Christopher [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Barbara Segura [Canada, Espagne] ; Isabelle Boileau [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Pablo Rusjan [Canada] ; Antonio P. Strafella [Canada] | Salience Network and Parahippocampal Dopamine Dysfunction in Memory-Impaired Parkinson Disease |
000938 |
Camila C. Aquino [Brésil] ; Tiago Mestre [Canada] ; Anthony E. Lang [Canada] | Restless genital syndrome in Parkinson disease. |
000945 |
Naomi P. Visanji [Canada] ; Connie Marras ; Louis W C. Liu ; Lili-Naz Hazrati ; Anthony E. Lang | Reply to: Gray et al. |
000A15 |
Hubert H. Fernandez [États-Unis] ; David G. Standaert [États-Unis] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Victor Sc Fung [Australie] ; Fabian Klostermann [Allemagne] ; Mark F. Lew [États-Unis] ; Per Odin [Suède] ; Malcolm Steiger [Royaume-Uni] ; Eduard Z. Yakupov [Russie] ; Sylvain Chouinard [Canada] ; Oksana Suchowersky [Canada] ; Jordan Dubow [États-Unis] ; Coleen M. Hall [États-Unis] ; Krai Chatamra [États-Unis] ; Weining Z. Robieson [États-Unis] ; Janet A. Benesh [États-Unis] ; Alberto J. Espay [États-Unis] | Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson'd Disease: Final 12-Month, Open-Label Results |
000A23 |
Sang Soo Cho [Canada] ; Yuko Koshimori [Canada] ; Kelly Aminian [Canada] ; Ignacio Obeso [Canada] ; Pablo Rusjan [Canada] ; Anthony E. Lang [Canada] ; Zafiris J. Daskalakis [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Investing in the Future: Stimulation of the Medial Prefrontal Cortex Reduces Discounting of Delayed Rewards |
000A30 |
Anthony E. Lang [Canada] ; Connie Marras [Canada] | Initiating dopaminergic treatment in Parkinson's disease. |
000A40 |
Elizabeth J. Slow [Canada] ; Ronald B. Postuma ; Anthony E. Lang | Implications of nocturnal symptoms towards the early diagnosis of Parkinson's disease. |
000A42 |
Yuko Koshimori ; Barbara Segura ; Leigh Christopher ; Nancy Lobaugh ; Sarah Duff-Canning ; Romina Mizrahi ; Clement Hamani ; Anthony E. Lang ; Kelly Aminian ; Sylvain Houle ; Antonio P. Strafella | Imaging changes associated with cognitive abnormalities in Parkinson’s disease |
000B07 |
Adam L. Boxer [États-Unis] ; Anthony E. Lang [Canada] ; Murray Grossman [États-Unis] ; David S. Knopman [États-Unis] ; Bruce L. Miller [États-Unis] ; Lon S. Schneider [États-Unis] ; Rachelle S. Doody [États-Unis] ; Andrew Lees [Royaume-Uni] ; Lawrence I. Golbe [États-Unis] ; David R. Williams [Australie] ; Jean-Cristophe Corvol [France] ; Albert Ludolph [Allemagne] ; David Burn [Royaume-Uni] ; Stefan Lorenzl [Allemagne] ; Irene Litvan [États-Unis] ; Erik D. Roberson [États-Unis] ; Günter U. Höglinger [Allemagne] ; Mary Koestler [États-Unis] ; Clifford R. Jack [États-Unis] ; Viviana Van Deerlin [États-Unis] ; Christopher Randolph [États-Unis] ; Iryna V. Lobach [États-Unis] ; Hilary W. Heuer [États-Unis] ; Illana Gozes [Israël] ; Lesley Parker [Canada] ; Steve Whitaker [États-Unis] ; Joe Hirman [États-Unis] ; Alistair J. Stewart [Canada] ; Michael Gold [États-Unis] ; Bruce H. Morimoto [États-Unis] | Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. |
000B53 |
Naomi P. Visanji [Canada] ; Connie Marras ; Lili-Naz Hazrati ; Louis W C. Liu ; Anthony E. Lang | Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. |
000B77 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] | 'Don't delay, start today': delaying levodopa does not delay motor complications. |
000B81 |
Leigh Christopher [Canada] ; Yuko Koshimori [Canada] ; Anthony E. Lang [Canada] ; Marion Criaud [Canada] ; Antonio P. Strafella [Canada] | Uncovering the role of the insula in non-motor symptoms of Parkinson's disease |
000B87 |
Barbara S. Connolly [Canada] ; Anthony E. Lang [Canada] | Pharmacological Treatment of Parkinson Disease A Review |
000B96 |
Kenneth Marek [États-Unis] ; John Seibyl [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] ; Chris Hyson [Canada] ; Danna Jennings [États-Unis] | Longitudinal follow-up of SWEDD subjects in the PRECEPT Study |
000B99 |
Jessie Theuns [Belgique] ; Aline Verstraeten [Belgique] ; Kristel Sleegers [Belgique] ; Eline Wauters [Belgique] ; Ilse Gijselinck [Belgique] ; Stefanie Smolders [Belgique] ; David Crosiers [Belgique] ; Ellen Corsmit [Belgique] ; Ellen Elinck [Belgique] ; Manu Sharma [Allemagne] ; Rejko Krüger [Allemagne] ; Suzanne Lesage [France] ; Alexis Brice [France] ; SUN JU CHUNG [Corée du Sud] ; Mi-Jung Kim [Corée du Sud] ; YOUNG JIN KIM [Corée du Sud] ; Owen A. Ross [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Ekaterina Rogaeva [Canada] ; ZHENGRUI XI [Canada] ; Anthony E. Lang [Canada] ; Christine Klein [Allemagne] ; Anne Weissbach [Allemagne] ; George D. Mellick ; Peter A. Silburn [Australie] ; Georgios M. Hadjigeorgiou [Australie] ; Efthimios Dardiotis [Grèce] ; Nobutaka Hattori [Japon] ; Kotaro Ogaki [Japon] ; Eng-King Tan [Singapour] ; YI ZHAO [Singapour] ; Jan Aasly [Norvège] ; Enza Maria Valente [Italie] ; Simona Petrucci [Italie] ; Grazia Annesi ; Aldo Quattrone ; Carlo Ferrarese ; Laura Brighina ; Angela Deutschl Nder ; Andreas Puschmann ; Christer Nilsson ; Gaëtan Garraux ; Mark S. Le Doux ; Ronald F. Pfeiffer ; Magdalena Boczarska-Jedynak ; Grzegorz Opala ; Demetrius M. Maraganore ; Sebastian Engelborghs [Belgique] ; Peter Paul De Deyn [Belgique, Pays-Bas] ; Patrick Cras ; Marc Cruts [Belgique] ; Christine Van Broeckhoven [Belgique] | Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease |
000C03 |
Francesca Antonelli [Canada] ; JI HYUN KO [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Franco Valzania [Italie] ; Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada] | Dopamine-Agonists and Impulsivity in Parkinson's Disease: Impulsive Choices vs. Impulsive Actions |
000C09 |
Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment |
000C12 |
Tiago A. Mestre [Canada] ; Prakesh Shah [Canada] ; Connie Marras [Canada] ; George Tomlinson [Canada] ; Anthony E. Lang [Canada] | Another face of placebo: The lessebo effect in Parkinson disease: Meta-analyses |
000C22 |
Ji Hyun Ko [Canada] ; Yuko Koshimori [Canada] ; Romina Mizrahi [Canada] ; Pablo Rusjan [Canada] ; Alan A. Wilson [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Voxel-based imaging of translocator protein 18kDa (TSPO) in high-resolution PET |
000C35 |
Pettarusp M. Wadia [Inde] ; Peter Howard ; Manuel Q. Ribeirro ; Jennifer Robblee ; Abena Asante ; David J. Mikulis ; Anthony E. Lang | The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders. |
000C42 |
Naomi P. Visanji [Canada] ; Patricia L. Brooks [Canada] ; Lili-Naz Hazrati [Canada] ; Anthony E. Lang [Canada] | The prion hypothesis in Parkinson's disease: Braak to the future |
000C50 |
James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie | The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques. |
000D01 |
Amaal Aldakheel ; Lorraine V. Kalia ; Anthony E. Lang | Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease |
000D55 |
William Reginold [Canada] ; Sarah Duff-Canning ; Christopher Meaney ; Melissa J. Armstrong ; Susan Fox ; Brandon Rothberg ; Cindy Zadikoff ; Nancy Kennedy ; David Gill ; Paul Eslinger ; Fred Marshall ; Mark Mapstone ; Kelvin L. Chou ; Carol Persad ; Irene Litvan ; Benjamin Mast ; David Tang-Wai ; Anthony E. Lang ; Connie Marras | Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. |
000D99 |
Francesca Antonelli [Canada] ; Ji Hyun Ko [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Franco Valzania [Italie] ; Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada] | Dopamine-Agonists and Impulsivity in Parkinson’s Disease: Impulsive Choices vs. Impulsive Actions |
000E17 |
Melissa J. Armstrong ; Irene Litvan ; Anthony E. Lang ; Thomas H. Bak ; Kailash P. Bhatia ; Barbara Borroni ; Adam L. Boxer ; Dennis W. Dickson ; Murray Grossman ; Mark Hallett ; Keith A. Josephs ; Andrew Kertesz ; Suzee E. Lee ; Bruce L. Miller ; Stephen G. Reich ; David E. Riley ; Eduardo Tolosa ; Alexander I. Tröster ; Marie Vidailhet ; William J. Weiner | Criteria for the diagnosis of corticobasal degeneration |
000E23 |
Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson’s disease with mild cognitive impairment |
000E45 |
Nancy J. Butcher ; Tim-Rasmus Kiehl ; Lili-Naz Hazrati ; Eva W. C. Chow ; Ekaterina Rogaeva ; Anthony E. Lang ; Anne S. Bassett | Association Between Early-Onset Parkinson Disease and 22q11.2 Deletion Syndrome |
000F04 |
Margarita Pondal [Canada] ; Connie Marras [Canada] ; Janis Miyasaki [Canada] ; Elena Moro [Canada] ; Melissa J. Armstrong [Canada] ; Antonio P. Strafella [Canada] ; Binit B. Shah [Canada] ; Susan Fox [Canada] ; L K Prashanth [Canada] ; Nicolas Phielipp [Canada] ; Anthony E. Lang [Canada] | Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic |
000F06 |
Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Pamela J. Mclean ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | α‐Synuclein oligomers and clinical implications for Parkinson disease |
000F10 |
Anthony E. Lang [Canada] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Olivier Rascol [France] | Trial designs used to study neuroprotective therapy in Parkinson's disease |
000F14 |
Ruth-Mary Desouza [Royaume-Uni] ; Elena Moro [France] ; Anthony E. Lang [Canada] ; Anthony H. V. Schapira [Royaume-Uni] | Timing of deep brain stimulation in Parkinson disease: A need for reappraisal? |
000F54 |
Ji Hyun Ko [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease |
000F72 |
Anthony E. Lang [Canada] ; Shirley Eberly [États-Unis] ; Christopher G. Goetz [États-Unis] ; Glenn Stebbins [États-Unis] ; David Oakes [États-Unis] ; Ken Marek [États-Unis] ; Bernard Ravina [États-Unis] ; Caroline M. Tanner [États-Unis] ; Ira Shoulson [États-Unis] | Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments |
001018 |
Janice C. Wong [Canada] ; Melissa J. Armstrong [Canada] ; Anthony E. Lang [Canada] ; Lili-Naz Hazrati [Canada] | Clinicopathological review of pallidonigroluysian atrophy |
001027 |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Alain Destée [France] ; Nobutaka Hattori [Japon] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Werner Poewe [Autriche] ; Mark Stacy [États-Unis] ; Eduardo Tolosa [Espagne] ; Haitao Gao [États-Unis] ; Jennifer Nagel [Suisse] ; Martin Merschhemke [Suisse] ; Ana Graf [Suisse] ; Christopher Kenney [États-Unis] ; Claudia Trenkwalder [Allemagne] | AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study |
001038 |
James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada] | The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques |
001047 |
Raymond T. Bartus [États-Unis] ; Tiffany L. Baumann [États-Unis] ; Joao Siffert [États-Unis] ; Christopher D. Herzog [États-Unis] ; Ron Alterman [États-Unis] ; Nicholas Boulis [États-Unis] ; Dennis A. Turner [États-Unis] ; Mark Stacy [États-Unis] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; C. Warren Olanow [États-Unis] | Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients |
001052 |
JI HYUN KO [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Prefrontal Dopaminergic Receptor Abnormalities and Executive Functions in Parkinson's Disease |
001066 |
William Reginold [Canada] ; Sarah Duff-Canning [Canada] ; Christopher Meaney [Canada] ; Melissa J. Armstrong [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; David Gill [États-Unis] ; Paul Eslinger [États-Unis] ; Fred Marshall [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin L. Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin Mast [États-Unis] ; David Tang-Wai [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada] | Impact of Mild Cognitive Impairment on Health-Related Quality of Life in Parkinson's Disease |
001189 |
Manu Sharma ; John P. A. Ioannidis ; Jan O. Aasly ; Grazia Annesi ; Alexis Brice ; Christine Van Broeckhoven ; Lars Bertram ; Maria Bozi ; David Crosiers ; Carl Clarke ; Maurizio Facheris ; Matthew Farrer ; Gaetan Garraux ; Suzana Gispert ; Georg Auburger ; Carles Vilari O-Güell ; Georgios M. Hadjigeorgiou ; Andrew A. Hicks ; Nobutaka Hattori ; Beom Jeon ; Suzanne Lesage ; Christina M. Lill ; Juei-Jueng Lin ; Timothy Lynch ; Peter Lichtner ; Anthony E. Lang ; Vincent Mok ; Barbara Jasinska-Myga ; George D. Mellick ; Karen E. Morrison ; Grzegorz Opala ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park ; Aldo Quattrone ; Ekaterina Rogaeva ; Owen A. Ross ; Leonidas Stefanis ; Joanne D. Stockton ; Wataru Satake ; Peter A. Silburn ; Jessie Theuns ; Eng-King Tan ; Tatsushi Toda ; Hiroyuki Tomiyama ; Ryan J. Uitti ; Karin Wirdefeldt ; Zbigniew Wszolek ; Georgia Xiromerisiou ; Kuo-Chu Yueh ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore ; Rejko Krüger | Large-scale replication and heterogeneity in Parkinson disease genetic loci |
001197 |
Zhengrui Xi ; Lorne Zinman ; Yakov Grinberg ; Danielle Moreno ; Christine Sato ; Juan M. Bilbao ; Mahdi Ghani ; Isabel Hernández ; Agustín Ruiz ; Mercè Boada ; Francisco J. Mor N ; Anthony E. Lang ; Connie Marras ; Amalia Bruni ; Rosanna Colao ; Raffaele G. Maletta ; Gianfranco Puccio ; Innocenzo Rainero ; Lorenzo Pinessi ; Daniela Galimberti ; Karen E. Morrison ; Catriona Moorby ; Joanne D. Stockton ; Mario Masellis ; Sandra E. Black ; Lili-Naz Hazrati ; Yan Liang ; Jan Van Haersma De With ; Luis Fornazzari ; Roque Villagra ; Ricardo Rojas-Garcia ; Jordi Clarim N ; Richard Mayeux ; Janice Robertson ; Peter St George-Hyslop ; Ekaterina Rogaeva | Investigation of C9orf72 in 4 Neurodegenerative Disorders |
001234 |
Nicola J. Ray [Canada] ; Janis M. Miyasaki [Canada] ; Mateusz Zurowski [Canada] ; Ji Hyun Ko [Canada] ; Sang Soo Cho [Canada] ; Giovanna Pellecchia [Canada] ; Francesca Antonelli [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study |
001282 |
Tiago A. Mestre [Canada] ; Anthony E. Lang ; A E Lang ; Joaquim J. Ferreira ; Vânia Almeida ; Mamede De Carvalho ; Janis Miyasaki ; Robert Chen ; Susan Fox | Associated movement disorders in orthostatic tremor. |
001329 |
Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
001358 |
Anthony E. Lang [Canada] ; Jose A. Obeso [Espagne] | Stem cell therapy for Parkinson's disease |
001380 |
Andrew Siderowf [États-Unis] ; Anthony E. Lang [Canada] | Premotor Parkinson's disease: Concepts and definitions |
001395 |
Igor N. Petrovic [Royaume-Uni] ; Helen Ling [Royaume-Uni, Serbie] ; Yasmine Asi [Serbie] ; Zeshan Ahmed [Serbie] ; Prashanth L. Kukkle [Canada] ; Lili-Naz Hazrati [Canada] ; Anthony E. Lang [Canada] ; Tamas Revesz [Serbie] ; Janice L. Holton [Serbie] ; Andrew J. Lees [Royaume-Uni, Serbie] | Multiple system atrophy–parkinsonism with slow progression and prolonged survival: A diagnostic catch |
001478 |
Binit B. Shah [Canada] ; Anthony E. Lang [Canada] | A case of neurosyphilis presenting with myoclonus, cerebellar ataxia, and speech disturbance |
001547 |
Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] ; Renato P. Munhoz [Brésil] ; Katia Charland [Canada] ; Amelie Pelletier [Canada] ; Mariana Moscovich [Brésil] ; Luciane Filla [Brésil] ; Debora Zanatta [Brésil] ; Silvia Rios Romenets [Canada] ; Robert Altman [Canada] ; Rosa Chuang [Canada] ; Binit Shah [Canada] | Caffeine for treatment of Parkinson disease: A randomized controlled trial |
001561 |
Elena Moro [Canada] ; Jason M. Schwalb ; Panida Piboolnurak ; Yu-Yan W. Poon ; Clement Hamani ; Serena W. Hung ; Tamara Arenovich ; Anthony E. Lang ; Robert Chen ; Andres M. Lozano | Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease. |
001688 |
Galit Kleiner-Fisman [Canada] ; Rebecca Martine [États-Unis] ; Anthony E. Lang [Canada] ; Matthew B. Stern | Development of a Non-Motor Fluctuation Assessment Instrument for Parkinson Disease |
001776 |
Pascal H. H. M. Van Lieshout [Canada] ; Catriona M. Steele [Canada] ; Anthony E. Lang [Canada] | Tongue control for swallowing in Parkinson's disease: Effects of age, rate, and stimulus consistency |
001784 |
Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | The curious case of phenocopies in families with genetic Parkinson's disease |
001789 |
Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis] | Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia |
001813 |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
001839 |
Valerie Voon [Royaume-Uni] ; Mandy Sohr [Allemagne] ; Anthony E. Lang [Canada] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Jacqueline Whetteckey [États-Unis] ; Daniel Weintraub [États-Unis] ; Glen R. Wunderlich [Canada] ; Mark Stacy [États-Unis] | Impulse control disorders in parkinson disease: A multicenter case–control study |
001851 |
Melissa J. Armstrong [Canada] ; Binit B. Shah [Canada] ; Robert Chen [Canada] ; Michael J. Angel [Canada] ; Anthony E. Lang [Canada] | Expanding the phenomenology of benign hereditary chorea: Evolution from chorea to myoclonus and dystonia |
001859 |
Richard A. Walsh [Canada] ; Anthony E. Lang [Canada] | Early‐onset tardive dyskinesia in a neuroleptic‐naive patient exposed to low‐dose quetiapine |
001881 |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
001898 |
Anthony E. Lang [Canada] | A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials |
001903 |
Elena Moro [Canada] ; Jason M. Schwalb [Canada, États-Unis] ; Panida Piboolnurak [Canada, États-Unis] ; Yu-Yan W. Poon [Canada] ; Clement Hamani [Canada] ; Serena W. Hung [Canada, États-Unis] ; Tamara Arenovich [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] ; Andres M. Lozano [Canada] | Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease |
001904 |
Christine Klein [Allemagne] ; Dimitri Krainc [États-Unis] ; Michael G. Schlossmacher [Canada] ; Anthony E. Lang [Canada] | Translational Research in Neurology and Neuroscience 2011: Movement Disorders |
001912 |
Anna Castrioto [Italie, Canada] ; Andres M. Lozano [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Melanie Fallis [Canada] ; Elena Moro [Canada] | Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation |
001A05 |
Mary C. Maj [Canada] ; Ilona Tkachyova ; Pratik Patel ; Jane B. Addis ; Nevena Mackay ; Valeriy Levandovskiy ; Jisoo Lee ; Anthony E. Lang ; Jessie M. Cameron ; Brian H. Robinson | Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells. |
001A31 |
Daniel Weintraub [États-Unis] ; Juergen Koester ; Marc N. Potenza ; Andrew D. Siderowf ; Mark Stacy ; Valerie Voon ; Jacqueline Whetteckey ; Glen R. Wunderlich ; Anthony E. Lang | Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. |
001B21 |
Renju Kuriakose [Canada] ; Utpal Saha [Canada] ; Gabriel Castillo [Canada] ; Kaviraja Udupa [Canada] ; Zhen Ni [Canada] ; Carolyn Gunraj [Canada] ; Filomena Mazzella [Canada] ; Clement Hamani [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Mojgan Hodaie [Canada] ; Robert Chen [Canada] | The Nature and Time Course of Cortical Activation Following Subthalamic Stimulation in Parkinson's Disease |
001B23 |
Pettarusp M. Wadia [Canada] ; Gamaliel Tan [Canada] ; Renato P. Munhoz [Canada] ; Susan H. Fox [Canada] ; Stephen J. Lewis [Canada] ; Anthony E. Lang [Canada] | Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation |
001B55 |
Shen-Yang Lim [Canada, Malaisie] ; Anthony E. Lang [Canada] | The nonmotor symptoms of Parkinson's disease—An overview |
001B58 |
Tiago Mestre [Portugal] ; Anthony E. Lang [Canada] | The grasp reflex: A symptom in need of treatment |
001B72 |
Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada] | Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) |
001B97 |
Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song Lu [République populaire de Chine] | Neuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia |
001C02 |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim L. Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
001C03 |
Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] | Long‐term effect of unilateral pallidotomy on levodopa‐induced dyskinesia |
001C06 |
Zhen Ni [Canada] ; Andrew D. Pinto [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Involvement of the cerebellothalamocortical pathway in Parkinson disease |
001C38 |
Anthony E. Lang [Canada] ; Robert Chen [Canada] | Dystonia in complex regional pain syndrome type I |
001C39 |
Amitabh Gupta [Canada] ; Anthony E. Lang [Canada] | Drug‐induced cranial myoclonus |
001C40 |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
001C54 |
Susanne A. Schneider [Royaume-Uni, Allemagne] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] ; Benedikt Bader [Allemagne] ; Adrian Danek [Allemagne] ; Kailash P. Bhatia [Royaume-Uni] | Characteristic head drops and axial extension in advanced chorea‐acanthocytosis |
001C65 |
Daniel Weintraub [États-Unis] ; Mandy Sohr [Allemagne] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mark Stacy [États-Unis] ; Valerie Voon [Royaume-Uni] ; Jacqueline Whetteckey [États-Unis] ; Glen R. Wunderlich [Canada] ; Anthony E. Lang [Canada] | Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study |
001C73 |
Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew J. Lees [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni] | A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy |
001C92 |
Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] | Long-Term Effect of Unilateral Pallidotomy on Levodopa-Induced Dyskinesia |
001C95 |
Connie Marras [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] ; Yosuke Wakutani [Canada] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Edwin Yip [Canada] ; Renato P. Munhoz [Brésil] ; Katja Lohmann [Allemagne] ; Ana Dj Armati [Allemagne] ; Andrew Bi [Canada] ; Ekaterina Rogaeva [Canada] | LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation |
001D00 |
ZHEN NI [Canada] ; Andrew D. Pinto [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Involvement of the Cerebellothalamocortical Pathway in Parkinson Disease |
001D06 |
Daniel Weintraub [États-Unis] ; Juergen Koester [Allemagne] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mark Stacy [États-Unis] ; Valerie Voon [Canada] ; Jacqueline Whetteckey [États-Unis] ; Glen R. Wunderlich [Canada] ; Anthony E. Lang [Canada] | Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients |
001D16 |
Ron Levy [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] | Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy |
001D50 |
Anthony E. Lang [Canada] | When and how should treatment be started in Parkinson disease? |
001E03 |
Shen-Yang Lim [Canada] ; Susan H. Fox ; Anthony E. Lang | Overview of the extranigral aspects of Parkinson disease. |
001E36 |
Alberto J. Espay [Canada] ; Dorcas E. Beaton ; Francesca Morgante ; Carolyn A. Gunraj ; Anthony E. Lang ; Robert Chen | Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study. |
001E57 |
Thilo Van Eimeren [Canada] ; Bénédicte Ballanger [Canada] ; Giovanna Pellecchia [Canada] ; Janis M. Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: A Trigger for Pathological Gambling in Parkinson’s Disease? |
001E88 |
Valerie Voon [États-Unis, Canada] ; Paul Krack [France] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Kathy Dujardin [France] ; Michael Schpbach [France] ; Stephane Thobois [France] ; Filippo Tamma [Italie] ; Jan Herzog [Allemagne] ; Johan Samanta [Pays-Bas] ; Cynthia Kubu [États-Unis] ; Helene Rossignol [France] ; Yu-Yan Poon [Canada] ; Jean A. Saint-Cyr [Canada] ; Claire Ardouin [France] ; Elena Moro [Canada] | Reply: Parkinson's disease, DBS and suicide: a role for serotonin |
001E92 |
Andrew S. Lim [Canada, États-Unis] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Jonathan O. Dostrovsky [Canada] ; William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Richard A. Wennberg [Canada] ; Brian J. Murray [Canada] | Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons |
001F52 |
Benedicte Ballanger [Canada] ; Thilo Van Eimeren [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Philippe Boulinguez [France] ; Giovanna Pellecchia [Canada] ; Sylvain Houle [Canada] ; Yu Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Stimulation of the subthalamic nucleus and impulsivity: Release your horses |
001F65 |
Rosalind S. Chuang [Canada] ; Anthony E. Lang [Canada] | Rasagiline‐induced spontaneous ejaculation |
001F96 |
Christine Klein [Allemagne, Canada] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Anthony E. Lang [Canada] | Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond |
002035 |
Benedicte Ballanger [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Thilo Van Eimeren [Canada] ; Clement Hamani [Canada] ; Robert Chen [Canada] ; Roberto Cilia [Canada] ; Sylvain Houle [Canada] ; Yu Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: A [15O] H2O PET study |
002045 |
Ana Djarmati [Allemagne] ; Johann Hagenah [Allemagne] ; Kathrin Reetz [Allemagne] ; Susen Winkler [Allemagne] ; Maria Isabel Behrens [Chili] ; Heike Pawlack [Allemagne] ; Katja Lohmann [Allemagne] ; Alfredo Ramirez [Allemagne] ; Vera Tadi [Allemagne] ; Norbert Brüggemann [Allemagne] ; Daniela Berg [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; Ferdinand Binkofski [Allemagne] ; Vladimir S. Kosti [Serbie] ; Jens Volkmann [Allemagne] ; Thomas Gasser [Allemagne] ; Christine Klein [Allemagne] | ATP13A2 variants in early‐onset Parkinson's disease patients and controls |
002053 |
Anthony E. Lang [Canada] | When and how should treatment be started in Parkinson disease? |
002073 |
Shen-Yang Lim [Canada] ; Susan H. Fox [Canada] ; Anthony E. Lang [Canada] | Overview of the Extranigral Aspects of Parkinson Disease |
002093 |
Alberto J. Espay [Canada, États-Unis] ; Dorcas E. Beaton [Canada] ; Francesca Morgante [Canada, Italie] ; Carolyn A. Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Impairments of Speed and Amplitude of Movement in Parkinson's Disease: A Pilot Study |
002122 |
Antonio P. Strafella [Canada] ; Andres M. Lozano ; Benedicte Ballanger ; Yu-Yan Poon ; Anthony E. Lang ; Elena Moro | rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET study. |
002155 |
Daniel G. Healy [Royaume-Uni] ; Mario Falchi [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Vincenzo Bonifati [Pays-Bas] ; Alexandra Durr [France] ; Susan Bressman [États-Unis] ; Alexis Brice [France] ; Jan Aasly [Norvège] ; Cyrus P. Zabetian [États-Unis] ; Stefano Goldwurm [Italie] ; Joaquim J. Ferreira [Portugal] ; Eduardo Tolosa [Espagne] ; Denise M. Kay [États-Unis] ; Christine Klein [Allemagne] ; David R. Williams [Australie] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Jose Berciano [Espagne] ; Anthony Hv Schapira [Royaume-Uni] ; Timothy Lynch [Irlande (pays)] ; Kailash P. Bhatia [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Andrew J. Lees [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study |
002166 |
Susan H. Fox [Canada] ; Jonathan M. Brotchie ; Anthony E. Lang | Non-dopaminergic treatments in development for Parkinson's disease. |
002251 |
Valerie Voon [États-Unis] ; Paul Krack [États-Unis] ; Anthony E. Lang [États-Unis] ; Andres M. Lozano [États-Unis] ; Kathy Dujardin [États-Unis] ; Michael Schüpbach [États-Unis] ; James D Mbrosia [États-Unis] ; Stephane Thobois [États-Unis] ; Filippo Tamma [États-Unis] ; Jan Herzog [États-Unis] ; Johannes D. Speelman [États-Unis] ; Johan Samanta [États-Unis] ; Cynthia Kubu [États-Unis] ; Helene Rossignol [États-Unis] ; Yu-Yan Poon [États-Unis] ; Jean A. Saint-Cyr [États-Unis] ; Claire Ardouin [États-Unis] ; Elena Moro [États-Unis] | A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease |
002258 |
Monty A. Silverdale [Canada, Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Anthony E. Lang [Canada] | The spectrum of orolingual tremor—A proposed classification system |
002263 |
Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins |
002308 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] | Levodopa‐related motor complications—Phenomenology |
002334 |
Shen-Yang Lim [Australie] ; Michael J. Farrell [Australie] ; Stephen J. Gibson [Australie] ; Robert D. Helme [Australie] ; Anthony E. Lang [Canada] ; Andrew H. Evans [Australie] | Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? |
002368 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] | rCBF Changes Associated with PPN Stimulation in a Patient with Parkinson's disease : A PET Study |
002419 |
Cindy Zadikoff [États-Unis, Canada] ; Susan H. Fox [Canada] ; David F. Tang-Wai [Canada] ; Teri Thomsen [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Pettarusup Wadia [Canada] ; Janis Miyasaki [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada] | A Comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in Identifying Cognitive Deficits in Parkinson's Disease |
002426 |
Anthony E. Lang [Canada] | The progression of Parkinson disease: a hypothesis. |
002450 |
Joyce K H. Tang [Canada] ; Elena Moro ; Neil Mahant ; William D. Hutchison ; Anthony E. Lang ; Andres M. Lozano ; Jonathan O. Dostrovsky | Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease. |
002465 |
Jamie Purzner [Canada] ; Guillermo O. Paradiso ; Danny Cunic ; Jean A. Saint-Cyr ; Tasnuva Hoque ; Andres M. Lozano ; Anthony E. Lang ; Elena Moro ; Mojgan Hodaie ; Filomena Mazzella ; Robert Chen | Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humans. |
002498 |
Jong Sam Baik [Canada, Corée du Sud] ; Anthony E. Lang [Canada] | Gait abnormalities in psychogenic movement disorders |
002500 |
Connie Marras [Canada] ; Alexander Kopp [Canada] ; Feng Qiu [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada] | Antipsychotic use in older adults with Parkinson's disease |
002525 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
002526 |
Matthew O. Hebb [Canada] ; Paula Chiasson [Canada] ; Anthony E. Lang [Canada] ; Robert M. Brownstone [Canada] ; Ivar Mendez [Canada] | Sustained relief of dystonia following cessation of deep brain stimulation |
002527 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Ji Hyun Ko [Canada] ; Yu-Yan Poon [Canada] ; Elena Moro [Canada] | Subdural motor cortex stimulation in Parkinson's disease does not modify movement‐related rCBF pattern |
002536 |
Ana Djarmati [Allemagne] ; Miodrag Gužvi [Allemagne, Serbie] ; Anne Grünewald [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; David K. Simon [États-Unis] ; Angela M. Kaindl [Allemagne] ; Peter Vieregge [Allemagne] ; Anders O. H. Nygren [Pays-Bas] ; Christian Beetz [Allemagne] ; Katja Hedrich [Allemagne] ; Christine Klein [Allemagne] | Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation‐dependent probe amplification |
002566 |
Panida Piboolnurak [Canada, Thaïlande] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elena Moro [Canada] | Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease |
002569 |
Ronald B. Postuma [Canada] ; Christina Wolfson [Canada] ; Ali Rajput [Canada] ; A. Jon Stoessl [Canada] ; W. R. Wayne Martin [Canada] ; Oksana Suchowersky [Canada] ; Sylvain Chouinard [Canada] ; Michel Panisset [Canada] ; Mandar S. Jog [Royaume-Uni] ; David A. Grimes [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | Is there seasonal variation in risk of Parkinson's disease? |
002574 |
Jie-Yuan Li [Canada, Taïwan] ; Alberto J. Espay [Canada] ; Carolyn A. Gunraj [Canada] ; Pramod K. Pal [Canada] ; Danny I. Cunic [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Interhemispheric and ipsilateral connections in Parkinson's disease: Relation to mirror movements |
002613 |
Valerie Voon [États-Unis, Canada] ; Susan Fox [Canada] ; Tracy R. Butler [États-Unis] ; Anthony E. Lang [Canada] | Antidepressants and psychosis in Parkinson disease: a case series |
002625 |
Asha Kishore [Canada] ; Alberto J. Espay [Canada] ; Connie Marras [Canada] ; Thamer Al-Khairalla [Canada] ; Tamara Arenovich [Canada] ; Abena Asante [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] | Unilateral versus bilateral tasks in early asymmetric Parkinson's disease : Differential effects on bradykinesia |
002628 |
Anthony E. Lang [Canada] | The progression of Parkinson disease : A hypothesis |
002633 |
Irene Litvan [États-Unis] ; Glenda Halliday [Australie] ; Mark Hallett [États-Unis] ; Christopher G. Goetz [États-Unis] ; Walter Rocca [États-Unis] ; Charles Duyckaerts [France] ; Yoav Ben-Shlomo [Royaume-Uni] ; Dennis W. Dickson [États-Unis] ; Anthony E. Lang [Canada] ; Marie-Francoise Chesselet [États-Unis] ; William J. Langston [États-Unis] ; Donato A. Di Monte [États-Unis] ; Thomas Gasser [Allemagne] ; Theo Hagg [États-Unis] ; John Hardy [États-Unis] ; Peter Jenner [Royaume-Uni] ; Eldad Melamed [Israël] ; Richard H. Myers [États-Unis] ; Davis Jr Parker [États-Unis] ; Donald L. Price [États-Unis] | The etiopathogenesis of parkinson disease and suggestions for future research. Part I |
002652 |
Janis M. Miyasaki [Canada] ; Khalid Al Hassan [Canada] ; Anthony E. Lang [Canada] ; Valerie Voon [Canada] | Punding prevalence in Parkinson's disease |
002679 |
Valerie Voon [États-Unis] ; Teri Thomsen [Canada] ; Janis M. Miyasaki [Canada] ; Minella De Souza [Canada] ; Ariel Shafro [Canada] ; Susan H. Fox [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Mateusz Zurowski [Canada] | Factors associated with dopaminergic drug-related pathological gambling in parkinson disease |
002692 |
Andrew S. Lim [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Anthony E. Lang [Canada] ; Richard A. Wennberg [Canada] ; Brian J. Murray [Canada] | Characterization of REM-sleep associated ponto-geniculo-occipital waves in the human pons |
002722 |
Ronald B. Postuma [Canada] ; Anthony E. Lang ; Jessica Massicotte-Marquez ; Jacques Montplaisir | Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. |
002747 |
Elena Moro [Canada] ; Anthony E. Lang | Criteria for deep-brain stimulation in Parkinson's disease: review and analysis. |
002752 |
Moran Weinberger [Canada] ; Neil Mahant ; William D. Hutchison ; Andres M. Lozano ; Elena Moro ; Mojgan Hodaie ; Anthony E. Lang ; Jonathan O. Dostrovsky | Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. |
002767 |
Cindy Zadikoff [Canada] ; Ekaterina Rogaeva [Canada] ; Ana Djarmati [Allemagne] ; Christine Sato [Canada] ; Shabnam Salehi-Rad [Canada] ; Peter St. George-Hyslop [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] | Homozygous and heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients |
002784 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Jonathan M. Brotchie [Canada] | Translation of nondopaminergic treatments for levodopa‐induced dyskinesia from MPTP‐lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure |
002794 |
Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] | Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes |
002814 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
002822 |
Francesca Morgante [Canada] ; Alberto J. Espay [Canada] ; Carolyn Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias |
002828 |
Wendy R. Galpern [Canada] ; Anthony E. Lang [Canada, États-Unis] | Interface between tauopathies and synucleinopathies: A tale of two proteins |
002852 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
002856 |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation: Preoperative issues |
002901 |
Elena Moro [Canada] ; Yu-Yan W. Poon [Canada] ; Andres M. Lozano [Canada] ; Jean A. Saint-Cyr [Canada] ; Anthony E. Lang [Canada] | Subthalamic nucleus stimulation : Improvements in outcome with reprogramming |
002902 |
Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] | Subthalamic nucleus deep brain stimulation : Summary and meta-analysis of outcomes |
002913 |
Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] ; Jessica Massicotte-Marquez [Canada] ; Jacques Montplaisir [Canada] | Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder |
002963 |
Valerie Voon [Canada] ; Elena Moro ; Jean A. Saint-Cyr ; Andres M. Lozano ; Anthony E. Lang | Psychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic stimulation. |
002A13 |
Cindy Zadikoff [Canada] ; Anthony E. Lang [Canada] | Apraxia in movement disorders |
002A62 |
Ronald B. Postuma [Canada] ; Tamara Arenovich [Canada] ; Anthony E. Lang [Canada] | Does severity of Parkinson's disease vary according to season? |
002A83 |
Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; Yan Meng [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada] | Analysis of the glucocerebrosidase gene in Parkinson's disease |
002B06 |
Valerie Voon [Canada] ; Jean Saint-Cyr ; Andres M. Lozano ; Elena Moro ; YU YAN POON ; Anthony E. Lang | Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery |
002B07 |
Anthony E. Lang [Canada] ; Janis Miyasaki [Canada] ; C. Warren Olanow [Canada] ; A. Jon Stoessl [Canada] ; Oksana Suchowersky [Canada] | Progress in clinical neurosciences : A forum on the early management of Parkinson's disease |
002B11 |
Ash Kishore [Canada] ; Anthony E. Lang [Canada] | Normalization of voice in spasmodic dysphonia during transient global amnesia |
002B25 |
Joyce K. H. Tang [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Neil Mahant [Canada] ; Jonathan O. Dostrovsky [Canada] | Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients |
002B79 |
Ronald B. Postuma [Canada] ; Anthony E. Lang | Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? |
002B93 |
Anthony E. Lang [Canada] ; Jose A. Obeso | Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. |
002C09 |
Michael Samuel [Canada, Royaume-Uni] ; Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] | Voluntary control and a wider clinical spectrum of essential palatal tremor |
002C12 |
Anthony E. Lang [Canada] ; José A. Obeso [Espagne] | Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease |
002C21 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Orit Zamir [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elspeth Sime [Canada] ; Jean A. Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations |
002C42 |
Luiz C. M. Pereira [Canada] ; Vanessa N. Palter [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Neuronal activity in the globus pallidus of multiple system atrophy patients |
002C64 |
Renato P. Munhoz [Canada] ; Anthony E. Lang [Canada] | Gestes antagonistes in psychogenic dystonia |
002D00 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Orit Zamir [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elspeth Sime [Canada] ; Jean A. Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations |
002D04 |
Judit Horvath [Suisse] ; Robin D. Fross [États-Unis] ; Galit Kleiner-Fisman [Canada] ; René Lerch [Suisse] ; Hans Stalder [Suisse] ; Suzanne Liaudat [Suisse] ; William J. Raskoff [États-Unis] ; Keith D. Flachsbart [États-Unis] ; Harry Rakowski [Canada] ; Jean-Claude Pache [Suisse] ; Pierre R. Burkhard [Suisse] ; Anthony E. Lang [Canada] | Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists |
002D10 |
Ajmal Razmy [Canada] ; Anthony E. Lang [Canada] ; Colin M. Shapiro [Canada] | Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists |
002D26 |
Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] | Homocysteine and levodopa: Should Parkinson disease patients receive preventative therapy? |
002D30 |
Justus L. Groen [Canada] ; Toshitaka Kawarai [Canada] ; Anna Toulina [Canada] ; Chiara Rivoiro [Canada, Italie] ; Shabnam Salehi-Rad [Canada] ; Christine Sato [Canada] ; Angharad Morgan [Canada] ; YAN LIANG [Canada] ; Ronald B. Postuma [Canada] ; Peter St George-Hyslop [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | Genetic association study of PINK1 coding polymorphisms in Parkinson's disease |
002D50 |
Christine Sato [Canada] ; Angharad Morgan [Canada] ; Anthony E. Lang [Canada] ; Shabnam Salehi-Rad [Canada] ; Toshitaka Kawarai [Canada] ; YAN MENG [États-Unis] ; Peter N. Ray [Canada] ; Lindsay A. Farrer [États-Unis] ; Peter St George-Hyslop [Canada] ; Ekaterina Rogaeva [Canada] | Analysis of the glucocerebrosidase gene in Parkinson's disease |
002D51 |
Ekaterina Rogaeva [Canada] ; Janel Johnson [États-Unis] ; Anthony E. Lang [Canada] ; Cindy Gulick [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Toshitaka Kawarai [Canada] ; Christine Sato [Canada] ; Angharad Morgan [Canada] ; John Werner [États-Unis] ; Robert Nussbaum [États-Unis] ; Agnes Petit [Canada] ; Michael S. Okun [États-Unis] ; Aideen Mcinerney [États-Unis] ; Ronald Mandel [États-Unis] ; Justus L. Groen [Canada] ; Hubert H. Fernandez [États-Unis] ; Ron Postuma [Canada] ; Kelly D. Foote [États-Unis] ; Shabnam Salehi-Rad [Canada] ; YAN LIANG [Canada] ; Sharon Reimsnider [États-Unis] ; Anurag Tandon [Canada] ; John Hardy [États-Unis] ; Peter St George-Hyslop [Canada] ; Andrew B. Singleton [États-Unis] | Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease |
002D74 |
Rajeev Kumar [Canada] ; Andres M. Lozano ; Elspeth Sime ; Anthony E. Lang | Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor. |
002E04 |
Bradley F. Boeve [États-Unis] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] | Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia |
002E14 |
Alberto J. Espay [Canada] ; Peter Ashby [Canada] ; Ritsuko Hanajima [Canada] ; Mandar S. Jog [Canada] ; Anthony E. Lang [Canada] | Unique form of propriospinal myoclonus as a possible complication of an enteropathogenic toxin |
002E27 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study |
002E28 |
Alexandra Sailer [Canada, Allemagne] ; Gregory F. Molnar [Canada] ; Guillermo Paradiso [Canada] ; Carolyn A. Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Short and long latency afferent inhibition in Parkinson’s disease |
002E41 |
William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano | Pallidal neuronal activity: Implications for models of dystonia |
002E69 |
Stephen Hague [États-Unis] ; Ekaterina Rogaeva [Canada] ; Dena Hernandez [États-Unis] ; Cindy Gulick [États-Unis] ; Amanda Singleton ; Melissa Hanson [États-Unis] ; Janel Johnson [États-Unis] ; Roberto Weiser [États-Unis] ; Marisol Gallardo [Venezuela] ; Bernard Ravina ; Katrina Gwinn-Hardy ; Anthony Crawley ; Peter H. St. George-Hyslop [Canada] ; Anthony E. Lang [Canada] ; Peter Heutink [Pays-Bas] ; Vincenzo Bonifati [Pays-Bas, Italie] ; John Hardy [États-Unis] ; Andrew Singleton [États-Unis] | Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation |
002E71 |
Ronald B. Postuma [Canada, États-Unis] ; Yoshiaki Furukawa [Canada, États-Unis] ; Ekaterina Rogaeva [Canada, États-Unis] ; Peter H. St. George-Hyslop [Canada, États-Unis] ; Matt J. Farrer [Canada, États-Unis] ; Anthony E. Lang [Canada, États-Unis] | Dopa‐responsive dystonia presenting with prominent isolated bilateral resting leg tremor: Evidence for a role of parkin? |
002E76 |
Taresa Stefurak [Canada] ; David Mikulis [Canada] ; Helen Mayberg [Canada] ; Anthony E. Lang [Canada] ; Stephanie Hevenor [Canada] ; Peter Pahapill [États-Unis] ; Jean Saint-Cyr [Canada] ; Andres Lozano [Canada] | Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study |
002E77 |
Anthony E. Lang [Canada] | Corticobasal degeneration: Selected developments |
002E78 |
Anthony E. Lang [Canada] | Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look‐alike? |
002E85 |
Galit Kleiner-Fisman ; Ekaterina Rogaeva [Canada] ; William Halliday ; Sylvain Houle [Canada] ; Toshitaka Kawarai [Canada] ; Christine Sato [Canada] ; Helena Medeiros [Canada] ; Peter H. St. George-Hyslop [Canada] ; Anthony E. Lang [Canada] | Benign hereditary chorea: Clinical, genetic, and pathological findings |
002E88 |
Renato P. Munhoz [Canada] ; Ritsuko Hanajima [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada] | Acute effect of transcutaneous electrical nerve stimulation on tremor |
002F02 |
Aviva Abosch [Canada] ; Shitij Kapur [Canada] ; Anthony E. Lang [Canada] ; Doug Hussey [Canada] ; Elspeth Sime [Canada] ; Janis Miyasaki [Canada] ; Svlvain Houle [Canada] ; Andres M. Lozano [Canada] ; Philip Starr ; Giovanni Broggi ; Roy A. E. Bakay ; Nicholas Boulis ; Ali R. Rezai | Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Commentary |
002F08 |
Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] | Progression of gait, speech and swallowing deficits in progressive supranuclear palsy |
002F21 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman [Canada] ; Farooq I. Kahn [Canada] ; Elspeth Sime [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Motor cortical stimulation for parkinsonism in multiple system atrophy |
002F25 |
Rajeev Kumar [Canada, États-Unis] ; Andres M. Lozano [Canada] ; Elspeth Sime [Canada] ; Anthony E. Lang [Canada] | Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor |
002F26 |
Galit Kleiner-Fisman [Canada] ; David N. Fisman ; Elspeth Sime ; Jean A. Saint-Cyr ; Andres M. Lozano ; Anthony E. Lang | Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease |
003029 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
003032 |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
003049 |
Anette V. Nieves [Canada, États-Unis] ; Anthony E. Lang [Canada] | Treatment of excessive daytime sleepiness in patients with Parkinson's Disease with modafinil |
003061 |
Connie Marras [Canada] ; Paula Rochon [Canada] ; Anthony E. Lang [Canada] | Predicting motor decline and disability in Parkinson disease: A systematic review |
003068 |
Mohamed Shafiq [Canada] ; Anthony E. Lang [Canada] | Myoclonus in parkinsonian disorders |
003072 |
Jean A. Saint-Cyr [Canada] ; Tasnuva Hoque ; Luiz C. M. Pereira ; Jonathan O. Dostrovsky ; William D. Hutchison ; David J. Mikulis ; Aviva Abosch ; Elspeth Sime ; Anthony E. Lang ; Andres M. Lozano | Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging |
003083 |
Douglas E. Hobson [Canada] ; Anthony E. Lang [Canada] ; W. R. Wayne Martin [Canada] ; Ajmal Razmy [Canada] ; Jean Rivest [Canada] ; Jonathan Fleming [Canada] | Excessive daytime Sleepiness and sudden-onset Sleep in Parkinson disease: A survey by the Canadian Movement Disorders Group |
003095 |
Ron Levy [Canada] ; Peter Ashby [Canada] ; William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease |
003218 |
Robert Chen [Canada] ; Sameer Kumar [Canada] ; Rami R. Garg [Canada] ; Anthony E. Lang [Canada] | Impairment of motor cortex activation and deactivation in Parkinson's disease |
003266 |
Anette V. Nieves [Canada] ; Janis M. Miyasaki [Canada] ; Anthony E. Lang [Canada] | Acute onset dystonic camptocormia caused by lenticular lesions |
003271 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Lee Cyn Ang [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche] | 69‐Year‐old man with gait disturbance and parkinsonism |
003292 |
Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Pallidotomy for Parkinson's disease |
003305 |
Ron Levy [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] ; Peter Pahapill [États-Unis] ; John Romas [Canada] ; Jean Saint-Cyr [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] | Lidocaine and muscimol microinjections in subthalamic nucleus reverse parkinsonian symptoms |
003331 |
Robert Chen [Canada] ; Rami R. Garg [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Effects of internal globus pallidus stimulation on motor cortex excitability |
003342 |
Michael Y. Oh [Canada] ; Mojgan Hodaie [Canada] ; SEONG HO KIM [Canada] ; Ahmed Alkhani [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; M. Aml ; Frank Hsu ; Kim J. Burchiel ; Patrick I. Kelly ; Roy A. E. Bakay ; Alon Mogilner | Deep brain stimulator electrodes used for lesioning: Proof of principle. Commentaries |
003355 |
Daniel S. Sa [Canada] ; Shitij Kapur [Canada] ; Anthony E. Lang [Canada] | Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis |
003452 |
Wendy J. Lombardi ; Robert E. Gross ; Lisa L. Trepanier ; Anthony E. Lang ; Andres M. Lozano ; Jean A. Saint-Cyr [Canada] | Relationship of lesion location to cognitive outcome following microelectrode-guided pallidotomy for Parkinson's disease |
003511 |
Yoshiaki Furukawa [Canada] ; Mark Guttman [Canada] ; Steven P. Sparagana [États-Unis] ; Joel M. Trugman [États-Unis] ; Keith Hyland [États-Unis] ; Philip Wyatt [Canada] ; Anthony E. Lang [Canada] ; Guy A. Rouleau [Canada] ; Mitsunobu Shimadzu [Japon] ; Stephen J. Kish [Canada] | Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene |
003538 |
Christopher Dromey [Canada, États-Unis] ; Rajeev Kumar [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] | An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice |
003716 |
Robert E. Gross ; Wendy J. Lombardi ; Anthony E. Lang ; Jan Duff ; William D. Hutchison ; Jean A. Saint-Cyr [Canada] ; Ronald R. Tasker ; Andres M. Lozano | Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease |
003736 |
David A. Grimes [Canada] ; Catherine B. Bergeron [Canada] ; Anthony E. Lang [Canada] | Motor neuron disease‐inclusion dementia presenting as cortical‐basal ganglionic degeneration |
003758 |
Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anthony E. Lang [Canada] ; Esther Cubo [États-Unis] | Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state |
003763 |
Anthony S-I Pakiam [Canada] ; Anthony E. Lang [Canada] | Essential palatal tremor: Evidence of heterogeneity based on clinical features and response to sumatriptan |
003873 |
Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Jonathon O. Dostrovsky [Canada] | New developments in understanding the etiology of Parkinson's disease and in its treatment |
003B68 |
Anthony E. Lang [Canada] ; Andres Lozano [Canada] ; Ronald Tasker [Canada] ; Jan Duff [Canada] ; Jean Saint-Cyr [Canada] ; Lisa Trépanier [Canada] | Neuropsychological and behavioral changes and weight gain after medial pallidotomy |
003B77 |
Antonio Strafella [Canada] ; Antonio Ashby [Canada] ; Michael Munz [Canada] ; John O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] | Inhibition of voluntary activity by thalamic stimulation in humans: Relevance for the control of tremor |
003F93 |
Lisa M. Shulman [États-Unis] ; Anthony E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; Noble J. David [États-Unis] ; Noble J. Weiner [États-Unis] | What is it?. Case 1, 1995: Psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction |
004602 |
Scott G. Adams [Canada] ; Anthony E. Lang [Canada] | Can the Lombard effect be used to improve low voice intensity in Parkinson's disease? |
004D09 |
Anthony E. Lang [Canada] | Manipulating the dopaminergic system in Parkinson's disease |
004E25 |
Ann E. Taylor [Canada] ; Jean A. Saint-Cyr [Canada] ; Anthony E. Lang [Canada] ; Frank T. Kenny [Canada] | PARKINSON'S DISEASE AND DEPRESSION |
005129 |
Anthony E. Lang [Royaume-Uni, Canada] ; Christopher Ellis [Royaume-Uni] ; Heather Kingon [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Iris pigementation in idiopathic dystonia |
005585 |
Anette V. Nieves [Canada] ; Anthony E. Lang | Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. |
005609 |
Barbara S. Connolly [Canada] ; Anthony E. Lang [Canada] | Pharmacological treatment of Parkinson disease: a review. |
005662 |
Valerie Voon [Canada] ; Anthony E. Lang | Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease. |